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ROLE OF THE RECEPTOR FOR ADVANCED GLYCATION END-PRODUCTS 
(RAGE) IN ADIPOSE TISSUE: BROWNING EFFECT 
CYNTHIA SHIM 
ABSTRACT 
 Adipose tissue plays an essential role in the regulation of many metabolic 
processes. Excess caloric intake and decreased energy expenditure cause adipocyte 
hypertrophy and hyperplasia, leading to inflammation of the adipose tissue, which 
contributes to obesity. Recent data link the Receptor for Advanced Glycation End-
products (RAGE) to high fat diet (HFD)-induced obesity and subsequent metabolic 
dysfunction, but its function is incompletely understood. On HFD, the concentration of 
RAGE ligands, such as carboxy methyl lysine (CML) – advanced glycation end-products 
(AGE) epitopes, S100 calcium binding protein B (S100b), and high mobility group box 1 
(HMGB1) increases, activating RAGE and resulting in inflammation. However, deletion 
of RAGE protected against the HFD-induced obesity and resulted in increased overall 
energy expenditure. In this study, we tested the hypothesis that the protective mechanism 
of RAGE deletion is due, in part, to browning which involves inducing brown adipose 
tissue (BAT)-like properties in white adipose tissue (WAT).  The expression of 
uncoupling protein 1 (UCP1), which is usually only expressed in BAT, is increased in the 
WAT of RAGE knockout (RKO) mice. This effect was reproduced in vitro, by silencing 
the Ager gene in the adipocyte cell line C3H10T1/2. We propose that RAGE affects 
adipocyte phenotype by downregulating the expression of browning genes such as UCP1, 
and therefore is a key determinant of energy expenditure and adiposity.  Thus, RAGE 
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antagonism may promote BAT phenotype and function in WAT, reducing adiposity, 
which may have potential therapeutic implications for treating obesity.  
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INTRODUCTION 
 
 During the past 20 years there has been a dramatic increase in obesity in the 
United States and rates remain high. Overweight and obesity are both classifications for 
ranges of weight that are greater than what is generally considered healthy for a given 
height. For adults, overweight and obesity ranges are determined by calculating a number 
called the body mass index (BMI) which correlates with amount of body fat. An adult 
with a BMI between 25 and 29.9 is considered overweight. An adult with a BMI greater 
than 30 is considered obese. The most recent national data on obesity prevalence show 
that more than one-third of U.S. adults (35.7%) are obese (Center for Disease Control and 
Prevention, 2012). Obesity is closely related to many disorders, including type 2 diabetes 
mellitus, insulin resistance, dyslipidemia, and cardiovascular diseases (Malnick & 
Knobler, 2006). Diet, genetic predisposition factors and lifestyle influence both energy 
intake and expenditure levels (Figure 1). Obesity develops when energy intake exceeds 
energy expenditure. According to Tseng et al. (2010), a small portion of nutrient energy 
intake is lost in feces and urine; a portion is used for physiological needs; a variable 
portion is used in physical activity; while the majority is used for metabolic processes or 
is lost in the production of heat. Of the remaining energy loss, there is the heat produced 
during digestion and absorption of food (thermic effect of food), the thermic effect of 
exercise, and the energy dissipated in response to the environmental changes, such as 
cold temperature and diet. These latter forms of regulated heat production are referred to 
as adaptive thermogenesis, and occur primarily in the mitochondria of skeletal muscle 
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and brown fat; it is finely regulated and therefore has the potential to be manipulated 
therapeutically to serve as a target for obesity treatment (Tseng et al., 2010). While most 
current obesity therapies are focused on reducing caloric intake, recent data suggest that 
increasing cellular energy expenditure (bioenergetics) may be an attractive alternative 
approach (Tseng et al., 2010).  
 
Figure 1. Energy Balance. When the human body’s energy balance is shifted towards 
expenditure (out), there is less inflammation and lower risk of disease. However, when 
there is more energy in than out, the human body may become resistant to insulin and 
more susceptible to diseases. Abbreviations: FA (fatty acids); ATP (adenosine 
triphosphate); TG (triglycerides); NAFLD (non-alcoholic fatty liver disease); TIID (type 
2 diabetes); CVD (cardiovascular disease). Figure amended from Birerdinc et al., 2013. 
 
Adipose Tissue  
 Until the 1940s, adipose tissue was described as a type of connective tissue that 
contained lipid droplets. However, this slowly began to change as research showed that 
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adipose tissue is the site of calorie storage after feeding and is the source of circulating 
fatty acids during fasting (Rosen & Spiegelman, 2014). In the last decade, adipose tissue 
has become indisputably recognized as an active endocrine organ, with the discovery of 
adipose-derived cytokines, such as leptin, that act upon other major organs. The 
importance of adipose tissue as an endocrine organ along with the enormous increase in 
global obesity rates sparked a renewed interest in adipose tissue (Figure 2). 
 
Figure 2. Adipose Tissue Biology. Blue represents the total number of adipose papers 
when the term ‘adipose’ was searched in PubMed. Red represents adipose papers as a 
percentage of all papers. Important findings are indicated by publication year. Figure 
taken from Rosen & Spiegelman, 2014. 
 
 One of the exclusive characteristics of adipose tissue is its ability to change its 
dimensions. During overnutrition, adipose depots expand first by increasing the size of 
individual cells (hypertrophy) until a critical threshold of about 0.8 µg/cell is reached 
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(Krotkiewski et al., 1983). If overnutrition continues, there is an increased need to store 
excess calories. Thus, signals are released to recruit new adipocytes (hyperplasia) from 
the resident pool of progenitors by inducing their proliferation and/or differentiation 
(adipogenesis). In addition to the matrix of extracellular proteins that holds the adipose 
depots together, adipocytes are surrounded by a wide variety of cells that includes 
endothelial cells, fibroblasts, stem cells, and immune cells. In lean animals, tissue-
remodeling/wound healing, anti-inflammatory M2 macrophages dominate the adipose 
tissue resident population (Figure 3). However, in a continued state of overnutrition, 
more pro-inflammatory M1 macrophages infiltrate the adipose depot along with 
neutrophils, mast cells, B and T lymphocytes, etc., contributing to insulin resistance (Oh 
et al., 2012). 
 
Figure 3. Adipocyte-Immune Cell Interactions. The immune cell population in the lean 
adipose depot is predominated by M2 macrophages, eosinophils and regulatory T cells 
(Tregs). When overnutrition occurs, there is an accumulation of proinflammatory cells, 
including M1 macrophages, mast cells, and various T lymphocytes. Abbreviations: ICL 
(innate lymphoid cell). Figure taken from Rosen & Spiegelman, 2014. 
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Due to the association of adipose tissue with metabolic disease, the benefits of 
healthy adipose tissue are often overlooked. Besides its importance in energy 
homeostasis, adipose tissue also has important mechanical qualities. It protects delicate 
organs such as the eyes, and cushions body parts exposed to high levels of mechanical 
stress such as the heels and toes. It also plays an important role in providing thermal 
insulation (Rosen & Spiegelman, 2014). The most important role of adipose tissue by far 
is in regulation of energy balance and nutritional homeostasis. 
There are two main types of adipose tissue – WAT (white adipose tissue) and 
BAT (brown adipose tissue). The two types of WAT we studied are the visceral 
perigonadal adipose tissue (PGAT) and the inguinal subcutaneous adipose tissue (SCAT). 
The main function of WAT is to store excess energy in the form of triglycerides, whereas 
the BAT is specialized to oxidize fatty acids and dissipate energy as heat through UCP1 
(uncoupling protein 1)-mediated uncoupling of oxidative phosphorylation from ATP 
synthesis. White adipocytes are generally larger in size than brown adipocytes. White 
adipocytes are characterized by a single large lipid droplet, whereas brown adipocytes 
contain numerous small droplets. In addition, WAT has fewer mitochondria in 
comparison to BAT. Another important difference between the two is that WAT does not 
express UCP1. Under normal conditions, UCP1 expression is exclusive to BAT. Other 
major differences between WAT and BAT are listed in Table 1 (Birerdinc et al., 2013).   
 
Table 1. Characteristics of WAT and BAT. This table lists the major differences between 
WAT and BAT. Table amended from Birerdinc et al., 2013. 
????????????????????? ?????????????????????
??????????????????????????????? ???????????????? ??????????????
????????????????????????????????????? ????????????????????????????????????????
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??????????????????????????????????? ?????????????????????????????????????
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???????????
???????????????????????????????????????????????????????
???????????
??????????????????? ?????????????
???????????????????? ?????????????
 
Prior to 2007, BAT was considered to be nonexistent or nonfunctional in adult 
humans and only present in infants.  However, the study by Saito et al. (2009), together 
with three recent reports in the New England Journal of Medicine (Cypess et al., 2009; 
van Marken Lichtenbelt et al., 2009; Virtanen et al., 2009), demonstrates that healthy 
adult humans have significant depots of metabolically active BAT. Positron emission 
tomography is commonly used to detect highly metabolically active cancer cells based on 
their uptake of large amounts of fluoro-labeled 2-deoxyglucose (FDG). During these 
imaging studies, localized depots of fatty tissue were frequently identified as hot spots for 
FDG uptake. Specifically, tissue biopsies corresponding to the positron emission 
tomography–positive regions have the morphological and molecular characteristics of 
BAT, including expression of the BAT-specific protein UCP1. 
 
Figure 4. Locations of BAT. Examples of brown adipose tissue in a newborn (A) (Image 
taken from Merklin, 1974); a 13-year-old boy (B) (Image taken from Hong et al., 2011), 
an adult male (C) (Image taken from van Marken Lichtenbelt et al., 2002) and a morbidly 
obese male (D) (Image taken from Vijgen et al., 2011).  
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Recently, it was discovered that when some depots of WAT were subjected to 
certain stimuli (Figure 5) such as cold exposure, they could adopt a BAT phenotype, 
expressing a core program of thermogenic genes, including UCP1 (Wu et al., 2012). 
These inducible adipocytes are known as beige adipocytes. Beige adipocytes have low 
thermogenesis activity and a small number of mitochondria like white adipocytes, but 
when they are activated, they possess many BAT-like features, such as the presence of 
multilocular lipid droplets, abundant mitochondria, and UCP1 expression (Lo & Sun, 
2013). This suggests that beige adipocytes are programmed to be bifunctional – suited for 
energy storage in the absence of thermogenic stimuli, but fully capable of turning on heat 
production in the presence of appropriate signals (Wu et al., 2012). Browning of WAT 
has been shown to have anti-obesity effects in rodent models (Wu et al., 2013).  
	   8	  
 
Figure 5. Activators of BAT. Many activators of browning and thermogenesis have been 
discovered. Figure taken from Rosen & Spiegelman, 2014. 
 
RAGE 
 RAGE (Receptor for Advanced Glycation End-products) is a pattern recognition 
receptor that recognizes stress and inflammatory signals (Schmidt et al., 1992). RAGE is 
highly expressed on many immune cells and its expression is further enhanced when 
immune activation occurs. RAGE is also highly expressed on a variety of cells, including 
adipocytes (Schmidt et al, 1992). RAGE binds AGEs (advanced glycation end-products), 
which form during irreversible post-translational modification of proteins, lipids or 
nucleic acids. For example, glycolysis results in the formation of a number of reactive 
products that have the potential to interact with protein residues to rapidly form AGEs 
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(Barlovic et al., 2011). In addition to binding with AGEs, RAGE interacts with CML-
AGE epitopes (carboxy methyl lysine – advanced glycation end-products), S100b (S100 
calcium binding protein B), and HMGB1 (high mobility group box 1) (Schmidt et al., 
2000). The interaction between RAGE and these ligands released by inflamed, stressed 
and damaged cells is thought to result in pro-inflammatory gene expression. Increased 
expression of both RAGE and accumulation of its ligands are observed in a range of 
disorders characterized by chronic inflammation, such as rheumatoid arthritis, 
atherosclerosis, Alzheimer’s disease and the vascular complications of diabetes (Bierhaus 
et al., 2005).  
 RAGE is composed of a large extracellular domain, a single transmembrane 
domain, and a 43-amino-acid cytoplasmic tail (Dattilo et al., 2007). The ligand binding 
site has been identified to be in the V-type immunoglobulin-like extracellular domain, 
whereas the cytosolic tail mediates intracellular signaling (Barlovic et al., 2011). Splice 
variants of murine and human RAGE have also been identified, including soluble 
isoforms, whose roles are not yet completely understood (Kalea et al, 2009). The RAGE-
ligand interaction triggers activation of NF-κB and other signaling pathways (Figure 6). 
Increased expression of inflammatory cytokines follows, leading to an inflammatory 
response (Hofmann et al., 1999). In obesity, the combined effects of overnutrition, low-
energy expenditure, hyperglycemia and hyperlipidemia may augment the formation of 
AGEs that activate RAGE, producing inflammatory mediators that contribute to the 
development of obesity-associated complications (Gaens et al., 2013). 
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Figure 6. Variants of RAGE and an Overview of Key Post-receptor Events Following 
Full-length RAGE Activation. By triggering the NF-κB pathway, activation of RAGE 
triggers an inflammatory response. Figure amended from Barlovic et al., 2011. 
 
Hypothesis: Current Study 
RAGE plays a key role in adipocytes by contributing to high fat diet-induced 
obesity and its subsequent complications. Mice that are deficient in RAGE are resistant to 
high fat diet-induced obesity and also show increased energy expenditure and higher 
body temperatures (Song et al., 2014). It was in this context that we hypothesized that 
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there is a link between RAGE and regulation of UCP1, perhaps by the browning of 
WAT. 
 We tested the hypothesis that the reduced adiposity, increased energy expenditure 
and higher body temperature observed in RAGE null mice are a result of browning of 
WAT. To test our model in vivo, we assessed the expression levels of UCP1 in WAT of 
RAGE null mice compared with wild type (WT) mice. To test our hypothesis in vitro, we 
silenced RAGE in an adipocyte cell line and compared our findings to the appropriate 
control treatments. Our experiments show that UCP1 expression increases in the absence 
of RAGE. These findings reveal RAGE and its ligands as possible regulators of the 
browning of WATs and suggest that this browning may contribute to the protective 
mechanism of RAGE deficiency. This would have important medical implications 
because a BAT-like phenotype is associated with lower risk of obesity, making it a 
potential target for treating obesity.  
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MATERIALS AND METHODS 
  
Animals and diets 
 Homozygous RAGE null mice (C57BL/6 Ager -/- mice backcrossed >20 
generations into C57BL/6J (Jackson Laboratory, Bar Harbor ME)) and their littermate 
RAGE-expressing WT controls were used. All mice studied were male, had free access to 
food and water, and were subjected to 12-hour light/dark cycles. At 6 to 8 weeks of age, 
mice were fed HFD with 60% of calories from lard (diet D12492; Research Diets Inc., 
New Brunswick, NJ) or low fat diet (LFD) with 13% of calories from fat (5053; PicoLab 
Rodent Diet 20; Lab Diet, Brentwood, MO).  
 
Primary cultures of white adipocytes 
 PGAT from WT and RAGE null mice (RKO) were excised, rinsed in phosphate-
buffered saline (PBS), minced and treated with collagenase for 45 minutes to 1 hour at 
37°C with shaking. The digestion was stopped by adding pre-warmed high glucose 
Dulbecco's Modified Eagle Medium: Nutrient Mixture F-12 (DMEM/F12). Cell 
suspensions were filtered through a 100 µm filter and then centrifuged at 1000 rpm for 4 
minutes. The pellet was resuspended, filtered through a 40 µm filter and centrifuged at 
2000rpm for 10 minutes. Precursor cells were seeded to obtain 1500–2000 cells/cm2 on 
day 1 and grown in DMEM supplemented with 10% newborn calf serum (NCS), 3 
nm insulin, 10 mm HEPES, 50 IU penicillin and 50 µg streptomycin/ml, and 15 
µm ascorbic acid. Culture media were changed on day 1 and every second day thereafter. 
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Precursor cells proliferated actively in these conditions, reached confluence on days 4–5 
after seeding (40,000–80,000 cells/cm2), and were fully differentiated by day 8 into 
mature white adipocytes. Cells were used to check the expression on RAGE at different 
days of differentiation. 
 
Preparation of C3H10T1/2 cells 
 A vial of C3H10T1/2 cells was taken out of the dry ice tank and held in a 37°C 
bath to defrost. Cells were mixed into complete medium and centrifuged for 7 minutes at 
room temperature. The pellet was resuspended into complete medium and placed in a 
37°C incubator. The cells grew to about 80% confluence and were detached from the 
flask by adding trypsin and incubating for two minutes. The cells were centrifuged for 7 
minutes and the pellet was resuspended and either kept in complete medium at 37°C or 
frozen for future use. Cells were grown to confluence in DMEM, 10% (vol/vol) FBS and 
1% (vol/vol) penicillin-streptomycin followed by standard adipogenic induction (20nM 
insulin, 1nM T3, 0.5 mM isobutylmethylxanthine, 1µM dexamethasone, 0.125 mM 
indomethacin) and stimulation with a prototypic AGE prepared in our laboratory, 
carboxy methyl lysine (CML) AGE or vehicle. RNA and protein from mature cells were 
prepared. After a total of 12 days of incubation, cells exhibited a fully differentiated 
phenotype with substantial lipid droplet accumulation.  
 
Cell transfection 
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 24 hours prior to transfection, the medium was changed to Optimem. 
Undifferentiated C3H10T1/2 cells were transfected with Ambion Silencer RAGE siRNA 
or scramble control using lipofectamine and stored at 37°C. The next day, the medium 
was changed back to complete medium to allow the cells to recover for at least 24 hours 
in the incubator, before differentiation. 
 
Quantitative Real-Time PCR analysis 
 Tissue samples were homogenized in QIAzol reagent using a homogenizer. Total 
RNA from either homogenized tissues or differentiated C3H10T1/2 cells was isolated 
using RNeasy Mini columns following the mantufacturer’s instructions. cDNA was 
synthesized with multiscribe reverse transcriptase (Applied Biosystems, Foster City, CA). 
5µl of cDNA was used in a 20µl quantitative PCR reaction using the TaqMan method 
(50°C for 2 minutes, 95°C for 10 minutes, and 40 cycles of 95°C for 15 seconds and 
60°C for 1 minute) with premade primer sets (Applied Biosystems). PCR reactions were 
run in duplicate for each sample. The relative abundance of transcripts was normalized 
according to the expression of β-actin using the ΔΔCt method and mRNA expression was 
quantified using Microsoft Excel.  
 
Table 2. Target genes. This table lists the genes that were searched in our real-time PCR 
experiments. 
?????????? ???????????? ?????????
????????????????????????????????????????????????????? ????? ??????????????
???????? ????? ??????????????
???????????????????????????????????????????????????????????????????????????? ?????? ??????????????
???????????????????? ????? ??????????????
?????????????????????????? ?????? ??????????????
?????????????????????????? ????? ??????????????
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??????????????????????????????????????????????? ??????? ??????????????
????????????????????????????????????????????????????????? ??????? ??????????????
?????????????????????????????????????? ????? ??????????????
????????????????????????????????????????????????????? ????? ??????????????
   
Western Blot analysis 
 Tissue samples were homogenized in lysis buffer using a homogenizer and 
differentiated C3H10T1/2 cells were placed in lysis buffer. After lysis, lysates were 
purified by centrifugation at 11,000 rpm for 15 minutes at 4°C. The supernatants were 
isolated and protein concentration was quantified using the Thermo Scientific Pierce 
BCA Protein Assay kit. Proteins were separated by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to nitrocellulose 
membranes. Membranes were blocked for 20 minutes at room temperature to reduce non-
specific antibody binding. Then, the membranes were incubated with the primary 
antibodies overnight at 4°C. After triple-washing the membranes to remove unbound 
primary antibody, membranes were incubated with secondary antibodies for one hour at 
room temperature. Membranes were triple-washed again and the presence of specific 
proteins was visualized using Odyssey. Protein expression levels were quantified using 
Image J and Microsoft Excel. 
 
Statistical Analyses 
 All data are reported as mean ± standard error of the mean. Statistical significance 
between two groups was determined by two-tailed Student’s t-test using Microsoft Excel. 
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Statistical significance between four groups was determined with a one-way ANOVA 
followed by an unpaired, two-tailed student’s t-test for P value using IBM SPSS 
Advanced Statistics 20.0. A p value of 0.05 or less was considered statistically 
significant.	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RESULTS 
 
 To study the possible role of RAGE in specific adipose tissue stores, we analyzed 
its mRNA expression and protein levels in different fat depots of LFD-fed wild-type 
mice. RAGE expression was higher in interscapular BAT than the visceral white PGAT 
and the inguinal white SCAT (Figure 7A and B). These results suggested that RAGE 
might contribute to energy expenditure regulation and to obesity. 
 
 
Figure 7. RAGE expression in different fat depots. Two months after induction of LFD, 
PGAT, SCAT and BAT were extracted and subjected to (A) real time quantitative PCR 
for detection of Ager mRNA transcripts (N=5 mice/group) and (B) Western blot analysis 
for expression of RAGE in protein (N=3 mice/group).  
 
 To determine if RAGE plays a role in the inflammatory and metabolic responses 
to high fat feeding, we assessed the concentrations of three prototypical proinflammatory 
RAGE ligands – CML AGE, S100b and Hmgb1. Two months after the start of LFD or 
HFD, PGAT, SCAT and BAT were retrieved and subjected to either real-time 
quantitative PCR for detection of Hmgb1 mRNA transcripts or Western blotting for 
detection of CML and S100b. The concentrations of both Hmgb1 mRNA transcripts and 
CML-AGE were significantly higher in the PGAT of mice fed HFD than in mice fed 
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LFD (Figure 8A and B). In addition, Western blots for expression of S100b showed an 
increase of S100b in all adipose tissue depots of HFD mice (Figure 8C). Expression of 
RAGE was also significantly higher in HFD mice (Figure 8D). 
 
 
Figure 8. HFD increases PGAT accumulation of Hmgb1 and CML. In mice fed HFD vs. 
LFD, PGAT was retrieved after two months of diet and subjected to real time quantitative 
PCR for detection of Hmgb1 mRNA transcripts (A) and Western blotting for detection of 
CML (B) (N=5 mice/group) and S100b (C) N=3 mice/group. After incubation of the 
blots with primary antibody, blots were stripped and re-probed with anti-β-actin IgG. 
Analysis of intensity of CML bands were normalized to β-actin. LFD and HFD 
adipocytes were subjected to real time quantitative PCR for detection of Ager mRNA 
transcripts (D). 
 
 In experiments performed previously by other members of the laboratory, RKO 
mice on HFD showed higher temperatures and increased energy expenditure when 
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compared with its WT counterparts (Figure 9A and B). RAGE null mice were protected 
from the weight gain seen in WT mice fed HFD (Figure 9C). These data suggested that 
RAGE deficiency protects against effects of HFD on local adipose tissue inflammation 
and insulin resistance, possibly due, in part, to the increased body temperature. 
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Figure 9. RAGE null mice are resistant to HFD induced obesity. WT or RKO mice were 
placed on either LFD or HFD. Body temperature was monitored (A) N=6 mice/group. 
Mice were placed in metabolic chambers for assessment of VO2 (B) and VCO2 (C) at 
baseline, 3 weeks HFD and 6 weeks HFD, N=6 mice/group. Body mass was measured 
(D) N=7-8 mice/group. * indicates p<0.001 comparing WT vs. RKO mice fed HFD. 
Figures taken from Song et al., 2014. 
 
 These findings prompted us to assess the levels of the thermogenic gene Ucp1 in 
BAT, PGAT and SCAT of WT vs. RKO mice on HFD. Ucp1 mRNA transcripts were 
significantly higher in PGAT of RKO vs. WT mice on HFD (Figure 10A), which 
suggests that RAGE deficiency induces a BAT gene program in WAT of HFD mice. To 
further characterize adipose tissue in the presence or absence of RAGE, we measured 
mRNA expression of known BAT markers including PGC-1α (encoded by Ppargc1a), 
cell-death activator (Cidea), and transcription factor A (Tfam). Expression of all BAT 
marker genes was significantly increased in the visceral white PGAT, with Tfam being 
the only exception (Figure 10B). These data indicate that RAGE deficiency increases 
BAT marker expression in visceral WAT. 
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Figure 10. Markers of browning. BAT, PGAT and SCAT were retrieved for WT and 
RKO mice fed LFD and HFD and subjected to real time quantitative PCR for Ucp1 
expression (A). PGAT from WT and RKO mice fed LFD or HFD were retrieved and 
subjected to real-time quantitative PCR for detection of Ppargc1a, Cidea and Tfam 
mRNA transcripts (B). 
 
 To further investigate our findings of the increased uncoupling in RKO WAT, we 
used the C3H10T1/2 cell line, which is an established model of adipogenesis. There was 
a similar pattern of RAGE expression in primary preadipocytes obtained from mice and 
C3H10T1/2 – derived adipocytes, which demonstrates that the C3H10T1/2 cell line is an 
effective model of adipogenesis (Figure 11A and B). Photos taken before and after 
C3H10T1/2 cell differentiation show the accumulation of lipid droplets by day 12 of 
differentiation (Figures C and D). 
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Figure 11. C3H10T1/2 cell line as a model of adipogenesis. Compared to primary 
preadipocyte differentiation (A), adipocyte differentiation of the C3H10T1/2 cell line 
shows similar patterns of expression for RAGE. Photos were taken of the C3H10T1/2 
cells before differentiation (C) and after 12 days of differentiation (D). Both photos are 
taken at 40x magnification. 
 
To mimic deletion of RAGE in primary adipocytes, we silenced RAGE 
expression via short interfering (si)RNA transfection prior to differentiation. There was 
no difference in the expression of genes responsible for lipolysis (Pnpla2, Lipe) and 
lipogenesis (Fasn, Srebf1) in siRAGE cells as compared to the cells transfected with a 
scrambled sequence of the siRNA target sequence, i.e., negative control. As expected, 
silencing RAGE in these C3H10T1/2 cells significantly induced Ucp1 gene and protein 
expression as compared to the negative control (Figure 12A and B). This supports an 
experiment done in our lab previously that showed that when RAGE antibody was used 
to block RAGE in the cell line C3H10T1/2, UCP1 expression increased (Figure 12C). 
These results collectively suggest that RAGE expression suppresses browning gene 
expression programs such as UCP1. In addition, our results show that when RAGE is 
blocked, browning increases. 
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Figure 12. RAGE inhibits browning. C3H10T1/2 cells with RAGE silenced 
(siRAGE) and their controls (scramble) were subjected to Western blotting (A) and real-
time quantitative PCR (B) for detection of UCP1 (p<0.05). When compared to RAGE 
antibody-blocked C3H10T1/2 cells (C), both methods of stimulating RAGE deficiency 
show similar results. 	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DISCUSSION 
 
 Given its central role in obesity and subsequent complications, adipose tissue has 
become an important therapeutic target. Inducing BAT-like characteristics in WAT may 
be a therapeutic strategy for reducing adiposity. In mice, the metabolic rate of BAT is 
nearly two orders of magnitude higher than that in any other tissue (Cannon and 
Nedergaard, 2004). Rothwell and Stock (1979) calculated that 40 – 50 grams of BAT 
could account for 20% of daily energy expenditure, which would be astounding, given 
that there are at least 100 grams of BAT in a healthy adult person (van Marken 
Lichtenbelt et al., 2009). However, it is necessary to gain a better understanding of the 
pathways that promote and inhibit beige adipocyte thermogenesis in humans. 
 Previous research from our laboratory implicated important roles for RAGE 
expression in adipocytes and perhaps other cells such as macrophages by contributing to 
diet-induced obesity and subsequent metabolic dysfunction via activating inflammatory 
pathways. In comparison with their WT counterparts, RKO mice on HFD were shown to 
be resistant to obesity, have higher body temperatures, and increase energy expenditure. 
The goal of the current study was to determine if the protective mechanism of RAGE 
deletion is due to browning of WAT. To study the role of RAGE, 2 to 3 month old WT 
and RKO mice on LFD and HFD were used to visualize the effects on browning gene 
expression programs, particularly UCP1. Additionally, C3H10T1/2 cell lines were used 
to test if our results are consistent in vitro. 
The WT mice were first examined to illustrate the normal expression patterns of 
RAGE in adipose tissue. During LFD, RAGE showed an adipose depot-specific 
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expression pattern in WT mice, with expression highest in BAT and lowest in PGAT. 
During HFD, results showed that the absence or deficiency of RAGE increased 
expression of UCP1 and other classical BAT markers in PGAT, with minimal changes in 
SCAT and BAT. These results suggested a link between RAGE and browning. Our 
findings show that altering RAGE and/or its ligands can promote functional plasticity of 
adipocytes, and identify RAGE as a possible determinant of white vs. brown fat 
transformation. The possibility that other RAGE effects or UCP1-independent pathways 
might contribute to thermogenesis in RAGE deficiency cannot be ignored. Similarly, the 
specific mechanisms through which RAGE-ligand interactions induce a BAT-like 
thermogenic program remain to be clarified.  
Increased clearance of energy stores by brown and beige adipocytes could reduce 
the excess of triglycerides and glucose associated with obesity. Moreover, it could 
produce beneficial metabolic effects or protection from obesity. However, whether 
nutrients absorbed by beige adipocytes are used in nonshivering thermogenesis, as they 
are in classic brown adipocytes, remains unclear. Despite these uncertainties, the impact 
of RAGE on body temperature and energy expenditure in obese mice identifies RAGE as 
a novel therapeutic target in the treatment of obesity.  
Here we establish RAGE and its ligands as previously unidentified determinants 
of functional browning of WAT. From our findings, the presence of RAGE and its 
ligands suppresses browning. Therefore, deleting or blocking RAGE can activate a 
thermogenic program, promoting energy dissipation and limiting obesity. To date, no 
definitive therapy prevents the consequences of HFD and diminished energy expenditure. 
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Disruption of RAGE expression or function in visceral white fat could offer new 
opportunities in targeting and treating obesity and its associated complications. 
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